Aerie Pharmaceuticals Inc (AERI)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

4301 EMPEROR BOULEVARD DURHAM, NC 27703

Aerie Pharmaceuticals, Inc. operates a clinical stage pharmaceutical company. The company focuses on the discovery, development, and distribution of pharmaceutical products for the treatment of glaucoma and other disease of the eye. Aerie Pharmaceuticals offers its products to the medical industry.

Data as of 2020-08-09
Market Cap585.965 Million Shares Outstanding46.468 Million Avg 30-day Volume767.447 Thousand
P/E Ratio Dividend Yield EPS-4.4
Price/Sales9.222 Price cash flow ratio Price free cash flow ratio-5.3
Book Value2.74 Price to Tangible Book4.61 Alpha0.0
Short Interest Ratio % Short Interest to Float R-squared0.035539
BETA0.894616 52-week High/Low26.26 / 10.8 Stddev0.199553
View SEC Filings from AERI instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 5 2 (0.13%)
13F Filers holding this stock: 153 49 (3.21%)
Aggregate 13F shares on 03/31/2020: 51.274 Million 26.429 Million
Aggregate 13F shares on 12/31/2019: 57.947 Million 25.364 Million
Percent change: -11.52% 4.20%
Funds creating new positions: 26 13
Funds Adding to an existing position: 53 17
Funds closing out their position: 35 12
Funds reducing their position: 49 12
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AERI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AERI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • Director
  • 10% Owner
18,716,306 2020-08-06 0

DUYK GEOFFREY M

  • Director
23,398 2020-08-05 0

MEHRA ANAND

  • Director
0 2020-06-30 0

CROARKIN RICHARD

  • Director
0 2020-06-18 1

MCGRAW BENJAMIN F III

  • Director
9,800 2020-06-11 1

CAGLE GERALD D.

  • Director
18,300 2020-06-11 2

GRYSKA DAVID W

  • Director
5,496 2020-06-11 1

DU TOIT MICHAEL

  • Director
8,100 2020-06-11 1

MCHUGH JULIE

  • Director
8,100 2020-06-11 1

MCDONNELL PETER J

  • Director
0 2020-06-09 2

GOLDBERG MURRAY A

  • Director
36,050 2020-05-18 1

ANIDO VICENTE JR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
225,550 2020-05-16 6

MITRO THOMAS A PRESIDENT AND COO

  • Officer
77,224 2020-05-16 4

RUBINO RICHARD J CHIEF FINANCIAL OFFICER

  • Officer
345,528 2020-05-16 5

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

FORESITE CAPITAL FUND III, L.P.

FORESITE CAPITAL FUND IV, L.P.

FORESITE CAPITAL MANAGEMENT III, LLC

FORESITE CAPITAL MANAGEMENT IV, LLC

TANANBAUM JAMES B.

  • 10% Owner
4,524,591 2020-02-27 6

KOPCZYNSKI CASEY C. CHIEF SCIENTIFIC OFFICER

  • Officer
226,114 2020-02-23 4

LAROCCA JOHN GENERAL COUNSEL

  • Officer
32,723 2020-02-19 4

FORESITE CAPITAL MANAGEMENT IV, LLC

FORESITE CAPITAL FUND IV, L.P.

TANANBAUM JAMES B.

  • 10% Owner
5,524,591 2019-12-20 4

HOLLANDER DAVID CHIEF R&D OFFICER

  • Officer
0 2019-11-11 2

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD PARTNERS, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
5,853,502 2018-07-23 0

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

FORESITE CAPITAL MANAGEMENT III, LLC

FORESITE CAPITAL FUND III, L.P.

TANANBAUM JAMES B.

  • 10% Owner
3,643,191 2017-05-26 0

LEVY BRIAN

  • Director
No longer subject to file 2016-02-10 0

CLARUS LIFESCIENCES II, L.P.

CLARUS VENTURES II GP, L.P.

CLARUS VENTURES II, LLC

GALAKATOS NICHOLAS

HENNER DENNIS

LIPTAK ROBERT

SIMON NICHOLAS

STEINMETZ MICHAEL

WHEELER KURT

  • 10% Owner
No longer subject to file 2016-02-08 0

ACP IV, L.P.

JANNEY DANIEL

NOHRA GUY P

ACMP IV LLC

  • 10% Owner
No longer subject to file 2014-07-16 0

SOFINNOVA VENTURE PARTNERS VII L P

SOFINNOVA MANAGEMENT VII, L.L.C.

HEALY JAMES

BUATOIS ERIC

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2014-07-09 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History

Holder Net Short Position Position Date Origin
HBK Investments L.P. Aerie Pharmaceuticals Inc 0.69% 2016-01-11 GERMANY
HBK Investments L.P. Aerie Pharmaceuticals Inc 0.59% 2016-02-18 GERMANY
HBK Investments L.P. Aerie Pharmaceuticals Inc 0.8% 2015-10-26 GERMANY
HBK Investments L.P. Aerie Pharmaceuticals Inc. 0.7% 2015-10-21 GERMANY
HBK Investments L.P. Aerie Pharmaceuticals Inc. 0.51% 2015-10-16 GERMANY
HBK Investments L.P. Aerie Pharmaceuticals Inc 0.79% 2015-12-07 GERMANY

Elevate your investments